United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 5 minute read Healthcare Industry News FDA clears Atia Vision’s OmniVu Lens for U.S. clinical trial, signaling a breakthrough in cataract surgery Atia Vision gets FDA green light to begin U.S. trials of its OmniVu™ Lens, aiming to restore full-range vision post-cataract surgery. See how it may redefine care. byPallavi MadhirajuMay 20, 2025